Did you know?
Innovating personalized care
Enable you to promote health for each patient by digitally connecting precise diagnoses with precise treatments.
There has been significant progress in the field of personalized healthcare, yet staggering challenges remain. While existing personalized diagnostic and therapeutic options have enabled precision medicine tailored to each patient's unique needs, these personalized treatments are still challenging to scale and have yet to become standard care. As a result, innovations in personalized healthcare are crucial to laying the groundwork that can benefit millions of patients. Personalized medicine needs to be scaled to a more accessible and standardized level by combining patient-centered best practices, actionable precision diagnostics, and impactful precision therapy.
Learn more about Innovating personalized care on this page and explore the opportunities:
Organize care around the
patient's medical condition
Implement innovative best-practice standards to organize care along the patient’s clinical pathway, enabling you to reduce unwarranted variations as a precondition for personalizing care.
Provide precise diagnosis
for actionable decisions
Integrate precise diagnostic data, enabling you to build a digital twin of the patient that provides a holistic understanding and actionable insights at the point of decision.
Deliver therapy outcomes
that matter to patients
Combine highly precise image guidance with minimally invasive, robot-assisted, and intelligent therapies, enabling you to deliver better patient outcomes with improved, lasting therapy results.
Download the whitepaper on Innovating personalized care
Explore how more nuanced diagnosis and more precise treatment can dramatically improve patient outcomes.
Discuss and share this whitepaper with your peers!
"Cancer care needs to be predictive, participatory, and personalized. Early detection is important, but treatment decisions should be based on predictions to improve patient outcomes."
Icon Cancer Centre, ASEAN and Hong Kong, Singapore
See sample solutions
Value Partnerships
Provide access to innovative medical technology that drives process standardization to reduce variations.
Gain insights on innovating personalized care
Watch our Shape 23 Keynote5:
Shaping healthcare in 2023 and beyond
We are sharing inspiring ideas and innovative solutions for three of the biggest challenges faced by healthcare providers:
Chapter "A world without fear of cancer"
To create a world without fear of cancer, we explore how to make oncology care more predictive and more precise.
Explore our Insights Center and find:
articles with directly applicable approaches | white papers | expert voices | studies | surveys
Stay tuned with regular executive insights
Subscribe to discover thought-provoking ideas, gain practical solutions to
today’s most pressing healthcare challenges, and receive our Insights Series.
Get our latest Insights Series papers
and more
Did this information help you?
The products/features (mentioned herein) are not commercially
available in all countries. Due to regulatory reasons their future
availability cannot be guaranteed. Please contact your local
Siemens Healthineers organization for further details.
The portfolio examples contribute to individual aspects of the stated
goals.
The statements by Siemens Healthineers’ customers described herein are based on results that were achieved in the customer's unique setting. Because there is no “typical” hospital or laboratory and many variables exist (e.g., hospital size, samples mix, case mix, level of IT and/or automation adoption) there can be no guarantee that other customers will achieve the same results.
1
Non-communicable diseases: Noncommunicable diseases (NCDs) are also known as chronic diseases. They tend to be of long duration and are the result of a combination of genetic, physiological, environmental and behavioral factors. The main types of NCDs are cardiovascular diseases (e.g., heart attacks and stroke), cancers, chronic respiratory diseases (e.g., chronic obstructive pulmonary disease and asthma) and diabetes.
2
Global Burden of Disease Collaborative Network, Global Burden of Disease Study 2019 (GBD 2019); World Health Organization
3
The information from the System assists the physician in the diagnosis.
4
Naeotom Alpha is not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.
5
Siemens Healthineers Shape Keynote is our annual signature event. It offers a unique blend of market expertise and Siemens Healthineers innovations. The keynote provides access to the knowledge of some of the world’s most respected healthcare thought leaders and unveils exclusive Siemens Healthineers breakthroughs for the first time.